| 1 |
Davies L,Morris LG,Haymart M, et al. American Association of Clinical Endocrinologists And American College of Endocrinology Disease State Clinical Review: the increasing incidence of thyroid cancer[J]. Endocr Pract, 2015, 21(6): 686-696.
|
| 2 |
Rossing M,Borup R,Henao R, et al. Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma[J]. J Mol Endocrinol, 2012, 48(1): 11-23.
|
| 3 |
Letsas KP,Frangou-Lazaridis M,Skyrlas A, et al. Transcription factor-mediated proliferation and apoptosis in benign and malig-nant thyroid lesions[J]. Pathol Int, 2005, 55(11): 694-702.
|
| 4 |
Cvejic D,Selemetjev S,Savin S, et al. Apoptosis and proliferation related molecules (Bcl-2, Bax, p53, PCNA) in papillary microcar-cinoma versus papillary carcinoma of the thyroid[J]. Pathology, 2008, 40(5): 475-480.
|
| 5 |
Selemetjev SA,Savin SB,Paunovic IR, et al. Changes in the ex-pression pattern of apoptotic molecules (galectin-3, Bcl-2, Bax, survivin) during progression of thyroid malignancy and their clini-cal significance[J]. Wien Klin Wochenschr, 2015, 127(9): 337-344.
|
| 6 |
Koc M,Aktimur R,Kagan Gokakin A, et al. Expression of FHIT, p16, p53 and EGFR as prognostic markers in thyroid tumors of uncertain malignant potential[J]. J BUON, 2015, 20(2): 567-572.
|
| 7 |
Jiang JL,Tian GL,Chen SJ, et al. Promoter methylation of p16 and RASSF1A genes may contribute to the risk of papillary thy-roid cancer: A meta-analysis[J]. Exp Ther Med, 2015, 10(4): 1549-1555.
|
| 8 |
Wu W,Yang SF,Liu FF, et al. Association between p16 Promoter Methylation and Thyroid Cancer Risk: A Meta-analysis[J]. Asian Pac J Cancer Prev, 2015, 16 (16): 7111-7115.
|
| 9 |
Hoffman AE,Yi CH,Zheng T, et al. CLOCK in breast tumorigen-esis: genetic, epigenetic, and transcriptional profiling analyses[J]. Cancer Res, 2010, 70(4): 1459-1468.
|
| 10 |
Kuo SJ,Chen ST,Yeh KT, et al. Disturbance of circadian gene expression in breast cancer[J]. Virchows Arch, 2009, 454(4): 467-474.
|
| 11 |
Rabstein S,Harth V,Justenhoven C, et al. Polymorphisms in cir-cadian genes, night work and breast cancer: results from the GEN-ICA study[J]. Chronobiol Int, 2014, 31(10): 1115-1122.
|
| 12 |
Zhu Y,Stevens RG,Hoffman AE, et al. Testing the circadian gene hypothesis in prostate cancer: a population-based case-con-trol study[J]. Cancer Res, 2009, 69(24): 9315-9322.
|
| 13 |
Oshima T,Takenoshita S,Akaike M, et al. Expression of circadi-an genes correlates with liver metastasis and outcomes in colorec-tal cancer[J]. Oncol Rep, 2011, 25(5): 1439-1446.
|
| 14 |
Wang Y,Qian R,Sun N, et al. Circadian gene hClock enhances proliferation and inhibits apoptosis of human colorectal carcinoma cells in vitro and in vivo[J]. Mol Med Rep, 2015, 11(6): 4204-4210.
|
| 15 |
Shalev M,Aviram R,Adamovich Y, et al. The PXDLS linear motif regulates circadian rhythmicity through protein-protein in-teractions[J]. Nucleic Acids Res, 2014, 42(19): 11879-11890.
|
| 16 |
Bell-Pedersen D,Cassone VM,Earnest DJ, et al. Circadian rhythms from multiple oscillators: lessons from diverse organisms[J]. Nat Rev Genet, 2005, 6(7): 544-556.
|
| 17 |
Shearman LP,Sriram S,Weaver DR, et al. Interacting molecular loops in the mammalian circadian clock[J]. Science, 2000, 288(5468): 1013-1019.
|
| 18 |
Levi F,Okyar A. Circadian clocks and drug delivery systems: im-pact and opportunities in chronotherapeutics[J]. Expert Opin Drug, 2011, 8(12): 1535-1541.
|
| 19 |
Peek CB,Ramsey KM,Levine DC, et al. Circadian regulation of cellular physiology[J]. Methods Enzymol, 2015, 552: 165-184.
|
| 20 |
Milev NB,Rey G,Valekunja UK, et al. Analysis of the redox os-cillations in the circadian clockwork[J]. Methods Enzymol, 2015, 552: 185-210.
|
| 21 |
Lévi F,Okyar A,Du long S, et al. Circadian timing in cancer treatments[J]. Annu Rev Pharmacol Toxicol, 2010, 50: 377-421.
|
| 22 |
朱晓灵,戴弘季,陈可欣,等. CLOCK基因单核苷酸多态性与乳腺癌易感性的病例对照研究[J].中国肿瘤临床, 2011, 38(3): 121-125.
|
| 23 |
邓香群,张鹏飞,贺印旎.生物钟基因hClock hBmal1在肿瘤中的表达研究[J].中国肿瘤临床, 2011, 38(10): 556-559.
|
| 24 |
Zhou F,He X,Liu H, et al. Functional polymorphisms of circadi-an positive feedback regulation genes and clinical outcome of Chi-nese patients with resected colorectal cancer[J]. Cancer, 2012, 118(4): 937-946.
|
| 25 |
Miller BH,McDearmon EL,Panda S, et al. Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation[J]. Proc Natl Acad Sci USA, 2007, 104(9): 3342-3477.
|
| 26 |
Yoshida D,Aoki N,Tanaka M, et al. The circadian clock controls fluctuations of colonic cell proliferation during the light/dark cy-cle via feeding behavior in mice[J]. Chronobiol Int, 2015, 32(8): 1145-1155.
|
| 27 |
Mannic T,Meyer P,Triponez F, et al. Circadian clock characteris-tics are altered in human thyroid malignant nodules[J]. J Clin En-docrinol Metab, 2013, 98(11): 4446-4456.
|